REFERENCES

1. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011;8:162-72.

2. Sannino A, Smith RL, Schiattarella GG, Trimarco B, Esposito G, et al. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol 2017;2:1130-9.

3. Godino C, Scotti A, Taramasso M, Adamo M, Russo M, et al. Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy. Int J Cardiol 2018;269:33-9.

4. Goliasch G, Bartko PE, Pavo N, Neuhold S, Wurm R, et al. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J 2018;39:39-46.

5. Adamo M, Godino C, Giannini C, Scotti A, Liga R, et al. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail 2018;21:196-204.

6. Godino C, Salerno A, Cera M, Agricola E, Fragasso G, et al. Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation. IJC Hear Vasc 2016;11:90-8.

7. Godino C, Munafò A, Sisinni A, Margonato A, Saia F, et al. MitraClip treatment of secondary mitral regurgitation in heart failure with reduced ejection fraction: lessons and implications from trials and registries. Structural Heart 2020:1-7.

8. Stone GW, Lindenfeld JA, Abraham WT, Kar S, Lim DS, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379:2307-18.

9. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297-306.

10. Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018;20:1505-35.

11. Baumwol J. “I Need Help” - A mnemonic to aid timely referral in advanced heart failure. J Hear Lung Transplant 2017;36:593-4.

12. Eurotransplant International Foundation. Annual Report 2018. Vol. 4. AIMS Mathematics; 2019. pp. 166-9. Available from: https://www.eurotransplant.org/wp-content/uploads/2020/05/ET_Jaarverslag_2018.pdf [Last accessed on 13 Jul 2020].

13. Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP study 2-year results. JACC Hear Fail 2017;5:518-27.

14. Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, et al. The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Hear Lung Transplant 2016;35:1-23.

15. Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail 2004;10:285-91.

16. Lancellotti P, Garbi M. Progression of secondary mitral regurgitation: From heart failure to valvular heart failure. Eur Heart J Cardiovasc Imaging 2018;19:613-4.

17. Packer M, Grayburn PA. New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation. JAMA Cardiol 2020; doi: 10.1001/jamacardio.2019.5971.

18. Packer M, Grayburn PA. Neurohormonal and transcatheter repair strategies for proportionate and disproportionate functional mitral regurgitation in heart failure. JACC Heart Fail 2019;7:518-21.

19. Packer M, Grayburn PA. Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart Failure. Circulation 2019;140:779-89.

20. Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 2019;12:353-62.

21. Food and Drug Administration. Summary of safety and effectiveness (SSED): MitraClip NT Clip Delivery System, MitraClip NTR/XTR Clip Delivery System. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf10/P100009S028B.pdf [Last accessed on 10 Jul 2020].

22. Adamo M, Cani DS, Gavazzoni M, Taramasso M, Lupi L, et al. Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair. EuroIntervention 2020; doi: 10.4244/EIJ-D-19-01114.

23. Bonow RO, O’Gara PT, Adams DH, Badhwar V, Bavaria JE, et al. 2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol 2020;75:2236-70.

24. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, et al. MitraClip^® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-76.

25. Garatti A, Castelvecchio S, Bandera F, Medda M, Menicanti L. Mitraclip procedure as a bridge therapy in a patient with heart failure listed for heart transplantation. Ann Thorac Surg 2015;99:1796-9.

26. Sankar NM, Ramani SS, Anantharaman R, Cherian KM. MitraClip and mitral annuloplasty device as a bridge to transplantation. Asian Cardiovasc Thorac Ann 2018;26:57-9.

27. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81.

28. Berardini A, Biagini E, Saia F, Stolfo D, Previtali M, et al. Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? Int J Cardiol 2017;228:191-7.

29. Geis NA, Pleger ST, Bekeredjian R, Chorianopoulos E, Kreusser MM, et al. Haemodynamic effects of percutaneous mitral valve edge-to-edge repair in patients with end-stage heart failure awaiting heart transplantation. ESC Hear Fail 2018;5:892-901.

30. Crimi G, Gritti V, Ghio S, Crescio V, Magrini G, et al. MitraClip procedure as ‘bridge to list’, the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension. Pulm Circ 2018;8:2045894018791871.

31. Godino C, Scotti A, Agricola E, Pivato CA, Chiarito M, et al. Young patient with advanced heart failure no longer a candidate for heart transplantation after MitraClip^® procedure. J Heart Valve Dis 2017;26:234-6.

32. Godino C, Munafò A, Scotti A, Estévez-Loureiro R, Portolés Hernández A, et al. Transcatheter mitral valve repair with MitraClip as bridge therapy for heart transplantation: one-year outcome from the international MitraBridge registry. EuroPCR - Late Breaking Trials 2019. Available from: https://media.pcronline.com/diapos/EuroPCR2019/3333-20190521_1600_Room_342A_Godino_Cosmo_1111_(7448)/Godino_Cosmo_20190521_1530_Room_342A.pdf [Last accessed on 13 Jul 2020].